Analysis of tumor growth rate for advanced hepatocellular cancer patients receiving placebo or sorafenib in the phase 3 SHARP and Asia Pacific trials — Gudrun Meinhardt (2016) | RDL Network
Josep M. Llovet, Thomas Decaens, Jean‐Luc Raoul, Éveline Boucher, Masatoshi Kudo, Cheng‐Chen Chang, Yang Kang, Éric Assenat, Ho-Yeong Lim, Valérie Boige, Philippe Mathurin, Lætitia Fartoux, Derek Lin, Jordi Bruix, Rtp Poon, Morris Sherman, J.-F. Blanc, Richard S. Finn, Won Young Tak, You‐Chen Chao, Rana Ezzeddine, D. Liu, Ian Walters, J.-W. Park
Peter R. Galle, Jean–Frédéric Blanc, Jean‐Luc Van Laethem, J. Marrero, Michel Beaugrand, M. Moscovici, Ming Shan, Andrea Nadel, D. Voliotis, Jordi Bruix, Josep M. Llovet
Discussion(0)
No comments yet. Be the first to comment.